1. Home
  2. PRTA vs JBSS Comparison

PRTA vs JBSS Comparison

Compare PRTA & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • JBSS
  • Stock Information
  • Founded
  • PRTA 2012
  • JBSS 1959
  • Country
  • PRTA Ireland
  • JBSS United States
  • Employees
  • PRTA N/A
  • JBSS N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • PRTA Health Care
  • JBSS Consumer Staples
  • Exchange
  • PRTA Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • PRTA 472.1M
  • JBSS 737.4M
  • IPO Year
  • PRTA N/A
  • JBSS 1991
  • Fundamental
  • Price
  • PRTA $8.18
  • JBSS $64.58
  • Analyst Decision
  • PRTA Buy
  • JBSS
  • Analyst Count
  • PRTA 10
  • JBSS 0
  • Target Price
  • PRTA $12.29
  • JBSS N/A
  • AVG Volume (30 Days)
  • PRTA 884.7K
  • JBSS 68.7K
  • Earning Date
  • PRTA 11-11-2025
  • JBSS 10-29-2025
  • Dividend Yield
  • PRTA N/A
  • JBSS 2.32%
  • EPS Growth
  • PRTA N/A
  • JBSS N/A
  • EPS
  • PRTA N/A
  • JBSS 5.03
  • Revenue
  • PRTA $10,341,000.00
  • JBSS $1,107,246,000.00
  • Revenue This Year
  • PRTA N/A
  • JBSS N/A
  • Revenue Next Year
  • PRTA $602.32
  • JBSS N/A
  • P/E Ratio
  • PRTA N/A
  • JBSS $12.77
  • Revenue Growth
  • PRTA N/A
  • JBSS 3.79
  • 52 Week Low
  • PRTA $4.32
  • JBSS $58.47
  • 52 Week High
  • PRTA $22.41
  • JBSS $97.47
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 52.33
  • JBSS 52.21
  • Support Level
  • PRTA $8.04
  • JBSS $62.60
  • Resistance Level
  • PRTA $8.39
  • JBSS $65.85
  • Average True Range (ATR)
  • PRTA 0.31
  • JBSS 1.45
  • MACD
  • PRTA -0.09
  • JBSS 0.09
  • Stochastic Oscillator
  • PRTA 24.14
  • JBSS 69.54

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: